Trial Profile
A Pilot Study of FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2020
Price :
$35
*
At a glance
- Drugs F-18 fluorothymidine (Primary)
- Indications Solid tumours
- Focus Diagnostic use
- 20 Mar 2020 Status changed from suspended to completed.
- 09 Jul 2019 Planned End Date changed from 1 Jun 2019 to 1 Dec 2019.
- 09 Jul 2019 Planned primary completion date changed from 1 Jun 2019 to 1 Dec 2019.